MedPath

Effect of clofibrate on serum triglycerid and cholestrol levels after intravenous lipid in very low birth weight neonates

Phase 3
Conditions
very low birth weight neonates.
Disorders related to short gestation and low birth weight, not elsewhere classified
Registration Number
IRCT201108021162N18
Lead Sponsor
Vice-chancellor for Research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

neonates with birth weight less than 1500 grams receiving intravenous lipid (IVL) for parental nutrition
Exclusion criteria: presence of any Congenital anomaly, hemolytic disease (Rh or ABO incompatibility OR a positive Coombs’ test), hyperbilirubenemia, Infection (congenital or acquired), dehydration, G6PD deficiency, history of Phenobarbital intake either by Mother or infant

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum cholesterol. Timepoint: before intervention and one day after intervention. Method of measurement: measurement of serum cholesterol.;Serum triglyceride. Timepoint: before intervention and one day after intervention. Method of measurement: measurement of serum triglyceride.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath